Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07697833 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients

Study acronym: VERICIGUAT
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To compare the effectiveness and safety of Vericiguat with Standard Medical Treatment in Patients with Heart Failure and Reduced Ejection Fraction
Trial Details
NCT Number NCT07697833
Lead Sponsor National Institute of Cardiovascular Diseases, Pakistan
Collaborators: Horizon Pharmaceuticals
Conditions
(from sponsor)		 Heart Failure With Reduced Ejection Fraction (HFrEF)
Related terms Cardiovascular Diseases, Heart Failure
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov